Products & Ingredients

Cognizin

Kyowa Hakko U.S.A., Inc. has trademarked its anti-aging Citicoline ingredient under the brand name of Cognizin™. Citicoline has been used in the treatment of neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging and head trauma. Scientific studies have indicated effectiveness in treating Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as glaucoma.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters